LH — Labcorp Holdings Income Statement
0.000.00%
Last trade - 00:00
- $18.66bn
- $23.56bn
- $12.16bn
- 87
- 43
- 85
- 83
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11,555 | 13,979 | 13,136 | 11,864 | 12,162 |
Cost of Revenue | |||||
Gross Profit | 3,253 | 4,953 | 4,992 | 3,709 | 3,365 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 10,230 | 11,476 | 10,088 | 10,427 | 11,436 |
Operating Profit | 1,325 | 2,503 | 3,049 | 1,437 | 726 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,105 | 2,219 | 2,888 | 1,237 | 569 |
Provision for Income Taxes | |||||
Net Income After Taxes | 825 | 1,557 | 2,198 | 1,004 | 380 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 824 | 1,556 | 2,377 | 1,279 | 418 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 824 | 1,556 | 2,377 | 1,279 | 418 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 9.57 | 19.5 | 22.7 | 13.7 | 7.37 |
Dividends per Share |